Health TrialsbyHealthPanel

Ureteral Stent Exchange Abstention in Urinary Tract Infections

ConditionsUrinary Tract InfectionsUrinary Catheterization
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCentral Hospital, Nancy, France

About this trial

The Committee of Infectiology of the French Association of Urology (CIAFU) provided, for the first time in 2020, comprehensive guidelines for ureteral stent-associated urinary tract infections (USAUTI) prevention, diagnosis and treatment. Since evidence lacked in terms of appropriate treatment, guidelines could not support systematic change of US in case of USAUTI.

This study aims to evaluate whether "after guidelines group" patients treated for USAUTI had different occurrence of at least one relapse or recurrence than "before guidelines group".

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients with indwelling ureteral catheter

AND confirmed or probable urinary tract infection

Disqualifiers

Patient's opposition

History of ileal conduit urinary diversion

Second or more urinary tract infection during the study period

Trial population

Groups will be selected from patients attending University Hospital of Nancy meeting the eligibility criteria during the period of inclusion running from January 1, 2018 to May 31, 2020 and from August 1, 2020 to December 31, 2022

Trial design

Design model

Other

Time perspective

Retrospective

Treatments tested in this trial

  • Guidelines promoting surgical abstention

    Other intervention

    Guidelines promoting surgical abstention

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: Before guidelines0 interventions
Group B: After guidelines1 intervention

Trial outcomes

Primary outcomes

1

Relapse OR recurrence of urinary tract infection

Time frame
1 year

Secondary outcomes

1

Nephro-urologic complication

Acute kidney injury ; hematuria ; pain ; stent migration or incrustation

Time frame
1 year
2

Infectious complication

Sepsis or septic shock

Time frame
1 year
3

In-hospital and 1-year mortality

all cause death

Time frame
1 year
4

Resort to Watch or Reserve antibiotics

antibiotics' WHO classifcation

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Central Hospital, Nancy, France

Lead sponsor

Source ClinicalTrials.gov
Apply now